A critical breakthrough in cancer investigation is occurring with the use of nanobodies to reactivate damaged p53. This crucial cancer protector protein is frequently inactivated in many types of cancer, causing https://mysocialquiz.com/story7567391/mini-antibodies-reactivate-tumor-suppressor-p53-new-potential-pathway-for-tumor-management